J. Moyer

发表

A Correlation of Bombesin‐Responsiveness with Myc‐Family Gene Expression in Small Cell Lung Carcinoma Cell Lines

E. Sausville, L. Neckers, J. Trepel, 1988, Annals of the New York Academy of Sciences.

Measurement and analysis of oxygen/nitrogen/5A-zeolite adsorption equilibria for air separation

Ravi Kumar, P. Mathias, J. Schork, 1996 .

Depletion of the erbB-2 gene product p185 by benzoquinoid ansamycins.

P. Miller, A. Bruskin, C. Diorio, 1994, Cancer research.

Antitumor activity and biochemical effects of cyclopentenyl cytosine in mice.

V. Marquez, J. Moyer, N. Malinowski, 1986, Cancer research.

Cyclopentenylcytosine triphosphate. Formation and inhibition of CTP synthetase.

Hee-Yong Kim, V. Marquez, D. Cooney, 1989, The Journal of biological chemistry.

Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor

J. O’Shea, A. Milici, B. Reitz, 2003, Science.

Correlation of Multicomponent Gas Adsorption by the Dual-Site Langmuir Model. Application to Nitrogen/Oxygen Adsorption on 5A-Zeolite

Ravi Kumar, S. Srinivasan, P. Mathias, 1996 .

p185erbB2 binds to GRP94 in vivo. Dissociation of the p185erbB2/GRP94 heterocomplex by benzoquinone ansamycins precedes depletion of p185erbB2.

L. Neckers, J. Trepel, E. Mimnaugh, 1996, The Journal of biological chemistry.

p185 Binds to GRP94 in Vivo

L. Neckers, J. Trepel, E. Mimnaugh, 1996, The Journal of Biological Chemistry.

Binding of benzoquinoid ansamycins to p100 correlates with their ability to deplete the erbB2 gene product p185.

P. Miller, M. Moyer, J. Moyer, 1994, Biochemical and biophysical research communications.

Inhibition of the oncogene product p185erbB-2 in vitro and in vivo by geldanamycin and dihydrogeldanamycin derivatives.

C. Diorio, M. Dee, J. Moyer, 1995, Journal of medicinal chemistry.

The Structural Basis for the Specificity of Epidermal Growth Factor and Heregulin Binding (*)

J. Stroh, D. Singleton, J. Moyer, 1995, The Journal of Biological Chemistry.

A novel bombesin receptor antagonist inhibits autocrine signals in a small cell lung carcinoma cell line.

E. Sausville, R. Jensen, J. Mulshine, 1988, Biochemical and biophysical research communications.

Novel single-pass exchange of circulating uridine in rat liver.

R. Handschumacher, J. Moyer, T. Gasser, 1981, Science.

Salvage of circulating pyrimidine nucleosides in the rat.

R. Handschumacher, J. Moyer, J. T. Oliver, 1981, Cancer research.

Metabolism of inositol bis-, tris-, tetrakis- and pentakis-phosphates in GH3 cells.

N. Dean, J. Moyer, 1988, The Biochemical journal.

Separation of multiple isomers of inositol phosphates formed in GH3 cells.

N. Dean, J. Moyer, 1987, The Biochemical journal.

The kinetics of phosphoinositide hydrolysis in rat basophilic leukemia (RBL-2H3) cells varies with the type of IgE receptor cross-linking agent used.

N. Dean, J. Cunha-Melo, M. Beaven, 1987, The Journal of biological chemistry.

Ultrasensitive assay for ribonucleoside triphosphates in 50-1000 cells. Application to studies with pyrazofurin and mycophenolic acid.

J. Moyer, J. F. Henderson, James D. Moyer, 1983, Biochemical pharmacology.

Compartmentation of intracellular nucleotides in mammalian cells.

J. Moyer, J. F. Henderson, J. Henderson, 1985, CRC critical reviews in biochemistry.

Salvage of circulating hypoxanthine by tissues of the mouse.

J. Moyer, J. F. Henderson, 1983, Canadian journal of biochemistry and cell biology = Revue canadienne de biochimie et biologie cellulaire.

Modulation of bombesin-induced phosphatidylinositol hydrolysis in a small-cell lung-cancer cell line.

E. Sausville, J. Trepel, J. Moyer, 1988, The Biochemical journal.

Antitumor activity and biochemical effects of aphidicolin glycinate (NSC 303812) alone and in combination with cisplatin in vivo.

P. O'dwyer, J. Plowman, T. Hamilton, 1994, Cancer research.

SYNTHESIS, BIOLOGICAL TESTING, AND STEREOCHEMICAL ASSIGNMENT OF AN END GROUP MODIFIED RETRO-INVERSO BOMBESIN C-TERMINAL NONAPEPTIDE

J. Jurayj, M. Cushman, J. Moyer, 1990 .

Antitumor Activity and Biochemical Effects of Aphidicolin Glycinate ( NSC 303812 ) Alone and in Combination with Cisplatin in Vivo 1

D. Harrison, J. Plowman, T. Hamilton, 2006 .

PF-03814735, an Orally Bioavailable Small Molecule Aurora Kinase Inhibitor for Cancer Therapy

L. Pustilnik, J. Christensen, B. D. Cohen, 2010, Molecular Cancer Therapeutics.

Ultrasensitive assay of RNA: application to 100-500 cells.

J. Moyer, J. F. Henderson, R. V. von Tigerstrom, 1983, Analytical biochemistry.

Cyclopentenyl uracil: an effective inhibitor of uridine salvage in vivo.

D. Zaharevitz, V. Marquez, R. Cysyk, 1995, Biochemical pharmacology.

Salvage of circulating pyrimidine nucleosides by tissues of the mouse.

J. Moyer, N. Malinowski, O. Ayers, 1985, The Journal of biological chemistry.

Defining effective microporosity in carbon molecular sieves

J. Armor, T. R. Gaffney, J. Moyer, 1994 .

Synthesis of Deoxy and Deoxyhalogeno Analogues of myo-Inositol

D. Baker, Cong Jiang, J. Moyer, 1987 .

Polyamine biosynthesis in rat prostate. Substrate and inhibitor properties of 7-deaza analogues of decarboxylated S-adenosylmethionine and 5'-methylthioadenosine.

J. Coward, J. Moyer, N. C. Motola, 1977, Journal of medicinal chemistry.

Nucleoside triphosphate specificity of firefly luciferase.

J. Moyer, J. F. Henderson, 1983, Analytical biochemistry.

Pulmonary cancer metastatic to the kidney--a common renal neoplasm.

C. Olsson, J. Moyer, R. Laferte, 1971, The Journal of urology.

Pyrazofurin metabolism, enzyme inhibition, and resistance in L5178Y cells.

A. Jakubowski, R. Handschumacher, J. Moyer, 1979, Cancer research.

Cyclopentenyluridine and cyclopentenylcytidine analogues as inhibitors of uridine-cytidine kinase.

V. Marquez, J. Moyer, M. Lim, 1984, Journal of medicinal chemistry.

The effect of 3-deazauridine and dipyridamole on uridine utilization by mice.

R. Cysyk, J. Moyer, N. Malinowski, 1986, European journal of cancer & clinical oncology.

Selective inhibition of pyrimidine synthesis and depletion of nucleotide pools by N-(phosphonacetyl)-L-aspartate.

R. Handschumacher, J. Moyer, 1979, Cancer research.

Kinetics of N-(phosphonacetyl)-L-aspartate and pyrazofurin depletion of pyrimidine ribonucleotide and deoxyribonucleotide pools and their relationship to nucleic acid synthesis in intact and permeabilized cells.

P. A. Smith, R. Handschumacher, J. Moyer, 1982, Cancer research.

Salvage of uridine in the mouse. Effect of uridine phosphorylase pretreatment.

J. Moyer, J. F. Henderson, 1985, Biochemical pharmacology.

Effect of an inhibitor of nucleoside transport on the disposition of uridine in mice.

A. Paterson, J. Moyer, J. F. Henderson, 1984, Biochemical pharmacology.

Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase.

L. Pustilnik, P. Miller, B. Boman, 1997, Cancer research.

SOME CONSEQUENCES OF INHIBITION OF THE DE NOVO PATHWAY OF PYRIMIDINE BIOSYNTHESIS

R. Handschumacher, J. Moyer, P. M. Schwartz, 1979 .

ErbB Tyrosine Kinases and the Two Neuregulin Families Constitute a Ligand-Receptor Network

M. Eisenstein, Y. Yarden, S. Bacus, 1998, Molecular and Cellular Biology.

Bivalence of EGF‐like ligands drives the ErbB signaling network

M. Eisenstein, Y. Yarden, R. Pinkas-Kramarski, 1997, The EMBO journal.

The biological and biochemical effects of CP-654577, a selective erbB2 kinase inhibitor, on human breast cancer cells.

L. Pustilnik, P. Miller, J. Kath, 2003, Cancer research.

Achieving selectivity between highly homologous tyrosine kinases: a novel selective erbB2 inhibitor.

A. Mathiowetz, L. Pustilnik, Joel Morris, 2003, Biochemical and biophysical research communications.

Inhibition of epidermal growth factor receptor-associated tyrosine phosphorylation in human carcinomas with CP-358,774: dynamics of receptor inhibition in situ and antitumor effects in athymic mice.

L. Pustilnik, M. Morin, T. Smolarek, 1999, The Journal of pharmacology and experimental therapeutics.

Discovery and pharmacologic characterization of CP-724,714, a selective ErbB2 tyrosine kinase inhibitor.

R. D. Connell, L. Pustilnik, Joel Morris, 2007, Cancer research.

Conservative management of renal artery embolus.

C. Olsson, J. Moyer, W. Widrich, 1973, The Journal of urology.

Combination Therapy Enhances the Inhibition of Tumor Growth with the Fully Human Anti–Type 1 Insulin-Like Growth Factor Receptor Monoclonal Antibody CP-751,871

Mark W Tengowski, Faye Wang, P. Miller, 2005, Clinical Cancer Research.

Effects of n-(phosphonacetyl)-l-aspartate (pala) on circulating pyrimidine nucleosides, nucleotide pools, and nucleic acid synthesis. Abstr.

P. A. Smith, R. Handschumacher, J. Moyer, 1980 .

Uptake and metabolism of myo-inositol by L1210 leukaemia cells.

J. Strong, J. Moyer, E. A. Napier, 1988, The Biochemical journal.

Pathogenic poxviruses reveal viral strategies to exploit the ErbB signaling network

Y. Yarden, S. Strano, J. Pierce, 1998, The EMBO journal.

The Biological and Biochemical Effects of CP-654577 , a Selective erbB 2 Kinase Inhibitor , on Human Breast Cancer Cells

L. Pustilnik, P. Miller, J. Kath, 2003 .

Oral diuretics and renal pain--a provocative test.

C. Olsson, J. Moyer, R. Chute, 1972, The Journal of urology.

LAS, a novel selective estrogen receptor modulator with chemopreventive and therapeutic activity in the N-nitroso-N-methylurea-induced rat mammary tumor model.

B. Pittman, L. Cohen, J. Moyer, 2001, Cancer research.

D-myo-inositol (1,4)-bisphosphate 1-phosphate. Partial purification from rat liver and characterization.

N. Dean, O. Reizes, J. Moyer, 1987, Biochemical and biophysical research communications.

ErbB Tyrosine Kinases and the Two Neuregulin Families Constitute a Ligand-Receptor Network

M. Eisenstein, Y. Yarden, S. Bacus, 1998, Molecular and Cellular Biology.

Synthesis and biological evaluation of isoprenylated coumarins as potential anti-pancreatic cancer agents.

J. Moyer, A. Bacay, Andrew C. Webb, 2014, Bioorganic & medicinal chemistry letters.

Infrared Determination of Hydroxyl Content of Oxidized Polyethylene.

J. Moyer, J. N. Lomonte, D. Kramm, 1964 .

P. A. Smith, R. Handschumacher, J. Moyer, 1982, Cancer research.

The discovery of highly selective erbB2 (Her2) inhibitors for the treatment of cancer.

L. Pustilnik, S. Bhattacharya, J. Chen, 2007, Bioorganic & medicinal chemistry letters.